Consequences of haemostasis disorders on anaesthestic management

Current Opinion in Anaesthesiology

Volumn 12, Issue 3, 1999, Pages 349-352

  Scherer, Ralf U ^a   Pulletz, Sven ^b  

^a Klinikum Niederrhein gGmbH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; APROTININ; D DIMER; PROCOAGULANT;

ANESTHESIA; BLOOD CLOTTING; BLOOD CLOTTING TEST; CARDIOPULMONARY BYPASS; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEAD INJURY; HEMATOLOGIC DISEASE; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REGIONAL ANESTHESIA; SEPSIS; SHORT SURVEY; THROMBOCYTE FUNCTION;

EID: 0032700639     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199906000-00017     Document Type: Short Survey

References (18)

1. Korte W, Truttmann B, Heim C, Stangl U, Schmid L, Kreienbuhl G. Preoperative values of molecular coagulation markers identify patients at low risk for intraoperative haemostatic disorders and excessive blood loss. Clin Chem Lab Med 1998; 36:235-240.
2. Gogarten W, van Aken H, Wulf H, Klose R, Vandermeulen E, Harenberg J. Rückenmarksnahe Regionalanästhesien und Thromboembolieprophytaxe/Antikoagulation. Anaesthesiologie Intensivmed 1997; 12:623-628. Guidelines and literature review on bleeding complications and regional anaesthesia.
3. Romsing J, Walther-Larsen S. Perioperative use of nonsteroidal anti-inflammatory drugs in children: analgesic efficacy and bleeding. Anaesthesia 1997; 52:673-683.
4. Niemi T, Svartling N, Syrjala M, Asko-Seljavaara S, Rosenberg P. Haemostatic disturbances in burned patients during early excision and skin grafting. Blood Coagul Fibrinolysis 1998; 9:19-28.
5. Scherer R, Spangenberg P. Procoagulant activity in patients with isolated severe head trauma. Crit Care Med 1998; 26:149-156.
6. Scherer R, Kabatnik M, Erhard J, Peters J. The influence of antithrombin III substitution to supra-normal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease. Intensive Care Med 1997; 23:1150-1158.
7. Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997; 96:2302-2310. The first experimental paper showing the effects of thrombin/antithrombin on the interaction of leukocytes and endothelial cells.
8. Uchiba M, Okajima K. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III. Semin Thromb Hemost 1997; 23:583-590.
9. Uchiba M, Okajima K, Murakami K. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb Res 1998; 89:233-241. An experimental paper establishing the link between antithrombin administration, endothelial prostacyclin release, and anti-inflammatory activity.
10. Inthorn D, Hoffmann JN, Hartl WH, Mühlbayer D, Jochum M. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock 1997; 8:328-334. The first clinical study showing a significant improvement of several organ functions by antithrombin administration in septic patients.
11. Eisele B, Lamy M, Thijs LG, Keinecke HO, Schuster HP, Matthias FR, et al. Antithrombin III in patients with severe sepsis. Intensive Care Med 1998; 24:663-672.
12. Eisele B, Lamy M. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin Thromb Hemost 1998; 24:71-80.
13. Miller BE, Tosone SR, Kanter KR, Guzzetta NA, Bailey JM, Levy JH. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thor Surg 1998; 66:535-540; discussion 541.
14. Boldt J. Endothelial-related coagulation in pediatric surgery. Ann Thorac Surg 1998; 65 (Suppl):S56-59; discussion S74-76.
15. Mossinger H, Dietrich W. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg 1998; 65 (6 Suppl): S50-S51.
16. Koscielny J, Blaicher AM, Felferning D, Latza R, Wenzel E, Kiesewetter H. Consensus use of desmopressin and antifibrinolytics in three university clinics. Anaesthesia 1998; 53 (Suppl 2):54-55.
17. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43:1684-1696.
18. Reyle-Hahn M, Rossaint R. Coagulation techniques are not important in directing blood product transfusion during liver transplantation. Liver Transpl Surg 1997; 3:659-663; discussion 663-665.